Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 29 Esophageal Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 15 Carcinoma, Non-Small-Cell Lung 14 Nasopharyngeal Carcinoma 12 Uterine Cervical Neoplasms 11 Head and Neck Neoplasms 11 Pancreatic Neoplasms 8 Oropharyngeal Neoplasms 8 Lung Neoplasms 6 Glioblastoma 6 Carcinoma, Squamous Cell 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Mouth Neoplasms 4 Hypopharyngeal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Neoplasms 4 Adenocarcinoma 4 Radiation Injuries 3 Pathologic Complete Response 3 Carcinoma 3 Breast Neoplasms 3 Thymoma 2 Resectable Esophageal Cancer 2 Neoplasms 2 Nasopharyngeal Neoplasms 2 NSCLC 2 Lymphoma 2 Lymphatic Metastasis 2

Interventions

Microscopy, Confocal 2 Indocyanine Green 2 Ultrasonography 1 Tumor Burden 1 Sunitinib 1 Simvastatin 1 Radiosurgery 1 Palliative Care 1 Observation 1 Neoadjuvant Therapy 1 Narrow Band Imaging 1 Mastectomy, Segmental 1 IFL protocol 1 Gastrectomy 1 Folfox protocol 1 Everolimus 1 Esophagectomy 1 Endoscopic Mucosal Resection 1 Drug Delivery Systems 1 Drug Combinations 1 Dermoscopy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Margins of Excision × Chemoradiotherapy × Clear all

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡